Literature DB >> 27747291

Elevated Energy Production in Chronic Fatigue Syndrome Patients.

Nick Lawson1, Chung-Han Hsieh1, Dana March2, Xinnan Wang1.   

Abstract

Chronic Fatigue Syndrome (CFS) is a debilitating disease characterized by physical and mental exhaustion. The underlying pathogenesis is unknown, but impairments in certain mitochondrial functions have been found in some CFS patients. To thoroughly reveal mitochondrial deficiencies in CFS patients, here we examine the key aspects of mitochondrial function in blood cells from a paired CFS patient-control series. Surprisingly, we discover that in patients the ATP levels are higher and mitochondrial cristae are more condensed compared to their paired controls, while the mitochondrial crista length, mitochondrial size, shape, density, membrane potential, and enzymatic activities of the complexes in the electron transport chain remain intact. We further show that the increased ATP largely comes from non-mitochondrial sources. Our results indicate that the fatigue symptom in this cohort of patients is unlikely caused by lack of ATP and severe mitochondrial malfunction. On the contrary, it might be linked to a pathological mechanism by which more ATP is produced by non-mitochondrial sources.

Entities:  

Keywords:  ATP; Chronic fatigue syndrome; complex activity; cristae; mitochondria

Year:  2016        PMID: 27747291      PMCID: PMC5065105     

Source DB:  PubMed          Journal:  J Nat Sci        ISSN: 2377-2700


  32 in total

Review 1.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome.

Authors:  Bart Smits; Lambert van den Heuvel; Hans Knoop; Benno Küsters; Antoon Janssen; George Borm; Gijs Bleijenberg; Richard Rodenburg; Baziel van Engelen
Journal:  Mitochondrion       Date:  2011-06-02       Impact factor: 4.160

3.  Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study.

Authors:  Graham Simmons; Simone A Glynn; Anthony L Komaroff; Judy A Mikovits; Leslie H Tobler; John Hackett; Ning Tang; William M Switzer; Walid Heneine; Indira K Hewlett; Jiangqin Zhao; Shyh-Ching Lo; Harvey J Alter; Jeffrey M Linnen; Kui Gao; John M Coffin; Mary F Kearney; Francis W Ruscetti; Max A Pfost; James Bethel; Steven Kleinman; Jerry A Holmberg; Michael P Busch
Journal:  Science       Date:  2011-09-22       Impact factor: 47.728

4.  The prevalence of chronic fatigue syndrome in Iceland - a national comparison by gender drawing on four different criteria.

Authors:  Eiríkur Líndal; Jón G Stefánsson; Sverrir Bergmann
Journal:  Nord J Psychiatry       Date:  2002       Impact factor: 2.202

5.  Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.

Authors:  O Marcillat; Y Zhang; K J Davies
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

6.  Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells.

Authors:  J Dörrie; H Gerauer; Y Wachter; S J Zunino
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

7.  Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria.

Authors:  C R Hackenbrock
Journal:  J Cell Biol       Date:  1966-08       Impact factor: 10.539

8.  Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome.

Authors:  Christopher R Snell; Staci R Stevens; Todd E Davenport; J Mark Van Ness
Journal:  Phys Ther       Date:  2013-06-27

9.  FABP4 reversed the regulation of leptin on mitochondrial fatty acid oxidation in mice adipocytes.

Authors:  Lu Gan; Zhenjiang Liu; Weina Cao; Zhenzhen Zhang; Chao Sun
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.379

10.  Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome.

Authors:  Fernando Galán; Isabel de Lavera; David Cotán; José A Sánchez-Alcázar
Journal:  J Investig Med High Impact Case Rep       Date:  2015-09-24
View more
  17 in total

1.  Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.

Authors:  Christina Mueller; Joanne C Lin; Sulaiman Sheriff; Andrew A Maudsley; Jarred W Younger
Journal:  Brain Imaging Behav       Date:  2020-04       Impact factor: 3.978

2.  Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses.

Authors:  Warren Tate; Max Walker; Eiren Sweetman; Amber Helliwell; Katie Peppercorn; Christina Edgar; Anna Blair; Aniruddha Chatterjee
Journal:  Front Neurol       Date:  2022-05-25       Impact factor: 4.086

Review 3.  The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.

Authors:  Marco Filippi; Rainer Krähenmann; Patrick Fissler
Journal:  Front Psychol       Date:  2022-06-21

Review 4.  Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?

Authors:  Benjamin Heng; Gilles J Guillemin; Bahar Kavyani; Brett A Lidbury; Richard Schloeffel; Paul R Fisher; Daniel Missailidis; Sarah J Annesley; Mona Dehhaghi
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

5.  Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS.

Authors:  Audrey E Brown; Beth Dibnah; Emily Fisher; Julia L Newton; Mark Walker
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

Review 6.  A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.

Authors:  Sean Holden; Rebekah Maksoud; Natalie Eaton-Fitch; Hélène Cabanas; Donald Staines; Sonya Marshall-Gradisnik
Journal:  J Transl Med       Date:  2020-07-29       Impact factor: 5.531

7.  Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types.

Authors:  Cara Tomas; Audrey E Brown; Julia L Newton; Joanna L Elson
Journal:  PeerJ       Date:  2019-03-01       Impact factor: 2.984

Review 8.  Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Daniel Missailidis; Sarah J Annesley; Paul R Fisher
Journal:  Diagnostics (Basel)       Date:  2019-07-20

Review 9.  Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.

Authors:  Anthony L Komaroff; W Ian Lipkin
Journal:  Trends Mol Med       Date:  2021-06-07       Impact factor: 11.951

10.  Cellular bioenergetics is impaired in patients with chronic fatigue syndrome.

Authors:  Cara Tomas; Audrey Brown; Victoria Strassheim; Joanna L Elson; Julia Newton; Philip Manning
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.